Clinical Trial Update: Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum [NA]

View source ↗

Summary

A completed clinical trial evaluating the Ulthera DeepSEE System for improving skin laxity in the lower face and submentum; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Laxity of the Lower Face
• Submentum Laxity

Drugs mentioned

• Ulthera DeepSEE System

Snippet

Sponsor: Merz North America, Inc. | Conditions: Improvement in Skin Laxity of the Lower Face and Submentum | NA | Status: COMPLETED | Results posted: 2023-02-15